Antimicrobial resistance—a threat to the world’s sustainable development

Upsala Journal of Medical Sciences

Volumn 121, Issue 3, 2016, Pages 159-164

  Jasovský, Dušan ^a   Littmann, Jasper ^a   Zorzet, Anna ^a   Cars, Otto ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antibiotic resistance; antimicrobial resistance; sustainable development; sustainable development goals

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANTIBIOTIC RESISTANCE; CATERING SERVICE; ENVIRONMENTAL PROTECTION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH PROMOTION; HUMAN; INTERNATIONAL COOPERATION; POVERTY; UNITED NATIONS; WATER SUPPLY; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTI-INFECTIVE AGENTS; CONSERVATION OF NATURAL RESOURCES; DRUG RESISTANCE, BACTERIAL; FOOD SUPPLY; HEALTH POLICY; HEALTH PROMOTION; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; POVERTY; UNITED NATIONS; WATER SUPPLY; WORLD HEALTH ORGANIZATION;

EID: 84978538361     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009734.2016.1195900     Document Type: Review

References (45)

1. Review on Antimicrobial Resistance. Tackling a crisis for the health and wealth of nations. London, United Kingdom: Review on Antimicrobial Resistance; 2014.
2. N.Daulaire, A.Bang, G.Tomson, J.N.Kalyango, O.Cars Universal access to effective antibiotics is essential for tackling antibiotic resistance. J Law Med Ethics. 2015;43(Suppl 3):17–21.
3. M.Mendelson, J.A.Røttingen, U.Gopinathan, D.H.Hamer, H.Wertheim, B.Basnyat,. Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries. Lancet. 2015;387:188–98.
4. World Health Organization. WHO global strategy for containment of antimicrobial resistance. Geneva: World Health Organization; 2001. Available at: http://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf?ua =1.
5. World Health Organization. Global action plan on antimicrobial resistance. Geneva: World Health Organization; 2015. Available at: http://www.who.int/drugresistance/global_action_plan/en/.
6. General Assembly Resolution 70/1. Transforming our world: the 2030 Agenda for Sustainable Development - A/RES/70/1. New York, USA: United Nations; 2015.
7. C.Nathan, O.Cars Antibiotic resistance – problems, progress, and prospects. N Engl J Med. 2014;371:1761–3.
8. R.Laxminarayan, A.Duse, C.Wattal, A.K.Zaidi, H.F.Wertheim, N.Sumpradit,. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057–98.
9. World Health Organization. Health in 2015: from MDGs to SDGs. Geneva: World Health Organization; 2015. Available at: http://www.who.int/gho/publications/mdgs-sdgs/en/.
10. ReAct - Action on Antibiotic Resistance. Toolbox - introduction. Uppsala, Sweden: ReAct; 2016. Available at: http://www.reactgroup.org/toolbox/.
11. A.D.So, T.A.Shah, S.Roach, Y.Ling Chee, K.E.Nachman An integrated systems approach is needed to ensure the sustainability of antibiotic effectiveness for both humans and animals. J Law Med Ethics. 2015:43(Suppl 3):38–45.
12. UN Commission on life-saving commodities for women and children. Commisioner's report. New York, USA: Every Women Every Child; 2012.
13. R.Laxminarayan, P.Matsoso, S.Pant, C.Brower, J.A.Røttingen, K.Klugman,. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387:168–175.
14. L.Liu, S.Oza, D.Hogan, J.Perin, I.Rudan, J.E.Lawn,. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2014;385:430–40.
15. World Health Organization. Global health estimates: deaths, disability-adjusted life year (DALYs), years of life lost (YLL) and years lost due to disability (YLD) by cause, age and sex. Geneva: World Health Organization; 2015. Available at: http://www.who.int/healthinfo/global_burden_disease/en/.
16. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: World Health Organization; 2012. doi: 10.1016/S0968-8080(12)40660-7.
17. M.Unemo, R.A.Nicholas Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012;7:1401–22.
18. Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: the growing threat of multidrug-resistant gonorrhea. MMWR Morb Mortal Wkly Rep. 2013;62:103–6.
19. M.S.Cohen Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet. 1998;351:S5–S7.
20. World Health Organization. Global Tuberculosis Report 2014. Geneva: World Health Organization; 2014. Available at: http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf.
21. TenoRes study group. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016 Jan 28 [Epub ahead of print]. Available at: http://www.thelancet.com/article/S1473309915005368/fulltext.
22. World Health Organization. World malaria report 2015. Geneva: World Health Organization; 2015. Available at: http://www.who.int/malaria/publications/world-malaria-report-2015/report/en/.
23. World Health Organization. Global tuberculosis report 2015. Geneva: World Health Organization; 2015. Available at: http://www.who.int/tb/publications/global_report/en/.
24. World Health Organization. Achieving the malaria MDG target: reversing the incidence of malaria 2000–2015. Geneva: World Health Organization; 2015. Available at: http://www.who.int/malaria/publications/atoz/9789241509442/en/.
25. A.Teillant, S.Gandra, D.Barter, D.J.Morgan, R.Laxminarayan Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis. 2015;15:1429–37.
26. C.Gudiol, J.Carratalà Antibiotic resistance in cancer patients. Expert Rev Anti Infect Ther. 2014;12:1003–16.
27. J.P.Nuorti, J.C.Butler, L.Gelling, J.L.Kool, A.L.Reingold, D.J.Vugia Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med. 2000;132:182–90.
28. G.Tomson, I.Vlad The need to look at antibiotic resistance from a health systems perspective. Ups J Med Sci. 2014;119:117–24.
29. White House. National action plan for combating multi-resistance tuberculosis. Washington D.C.: White House; 2015.
30. R.D.Smith, M.Yago, M.Millar, J.Coast Assessing the macroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistance. J Health Econ. 2005;24:1055–75.
31. D.Grace Review of evidence on antimicrobial resistance and animal agriculture in developing countries. London, United Kingdom: Evidence on Demand; 2015.
32. T.P.Van Boeckel, C.Brower, M.Gilbert, B.T.Grenfell, S.A.Levin, T.P.Robinson,. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA. 2015;112:5649–54.
33. D.W.Graham, C.W.Knapp, B.T.Christensen, S.McCluskey, J.Dolfing Appearance of β-lactam resistance genes in agricultural soils and clinical isolates over the 20(th) century. Sci Rep. 2016;6:21550.
34. Food and Agriculture Organization of United Nations & World Health Organization. Codex texts on foodborne antimicrobial resistance. Rome, Italy: Food and Agriculture Organization of United Nations & World Health Organization; 2015.
35. World Health Organization, Dept. of Communicable Disease Prevention, Control and Eradication; Danish Veterinary Institute; Danmarks jordbrugsforskning. Impacts of antimicrobial growth promoter termination in Denmark: the WHO international review panel’s evaluation of the termination of the use of antimicrobial growth promoters in Denmark: Foulum, Denmark 6–9 November 2002. Geneva: World Health Organization; 2003. Available at: http://www.who.int/iris/handle/10665/68357.
36. F.Baquero, J.-L.Martínez R.Cantón Antibiotics and antibiotic resistance in water environments. Curr Opin Biotechnol. 2008;19:260–5.
37. J.L.Martínez Antibiotics and antibiotic resistance genes in natural environments. Science. 2008;321:365–7.
38. D.G.J.Larsson, C.de Pedro, N.Paxeus Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater. 2007;148:751–55.
39. E.Gullberg, S.Cao, O.G.Berg, C.Ilbäck, L.Sandegren, D.Hughes,. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011;7:e1002158.
40. G.Heyman, O.Cars, M.-T.Bejarano, S.Peterson Access, excess, and ethics–towards a sustainable distribution model for antibiotics. Ups J Med Sci. 2014;119:134–41.
41. S.J.Hoffman, K.Outterson, J.A.Røttingen, O.Cars, C.Clift, Z.Rizvi,. An international legal framework to address antimicrobial resistance. Bull World Health Organ. 2015;93:66.
42. A.Zorzet Overcoming scientific and structural bottlenecks in antibacterial discovery and development. Ups J Med Sci. 2014;119:170–5.
43. L.L.Silver Challenges of antibacterial discovery. Clin Microbiol Rev. 2011;24:71–109.
44. C.Årdal, K.Outterson, S.J.Hoffman, A.Ghafur, M.Sharland, N.Ranganathan,. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2015;387:296–307.
45. O.Cars Securing access to effective antibiotics for current and future generations. Whose responsibility? Ups J Med Sci. 2014;119:209–14.